11 Hrs
Source:
الشبيبة
الشبيبة
Ready to play
Ready to play
The U.S. administration quickly approved a new drug for lung cancer treatment, intended for patients with specific conditions. This medication offers improved treatment options for patients suffering from certain types of lung cancer and is part of efforts to enhance the effectiveness of therapies while reducing side effects. Ongoing studies continue to verify its efficacy, and it is expected to contribute to higher success rates in the treatment of the disease.
Notice: This Is an AI-Generated Summary
Comments (0)